Will a new Israeli vaccine against coronavirus give immunity in the nose and lungs?
The governmental Israel Institute for Biological Research’s coronavirus vaccine has so far shown promising results in its ability to ward off variants that seem to be bypassing the Pfizer and Moderna inoculations.
The live virus vaccine’s Phase III trials are to take place in Georgia, Ukraine and other European countries.
Watch and learn about the vaccine’s development, why it’s so effective against variants, and why the BriLife vaccine may offer immunity in the nose and lungs.